Victor A, Weiner E, Johansson E D
Acta Endocrinol (Copenh). 1977 Oct;86(2):430-6. doi: 10.1530/acta.0.0860430.
In order to investigate the effect of changes in sex hormone binding globulin (SHBG) levels on d-norgestrel (d-Ng) levels in plasma, the plasma levels of SHBG and d-Ng were studied during one treatment cycle in 6 women on oral contraceptives containing d-Ng and ethinyloestradiol (EOE2) and in 3 women using subcutaneous silastic rods containing d-Ng concomitantly taking EOe2 for three weeks. A significant positive correlation between the SHBG and d-Ng levels was found in 7 of the 9 subjects studied. The results provide evidence for an in vivo binding of d-Ng to SHBG, a SHBG influence on the metabolic clearance rate of d-Ng and consequently a dependence of the plasma levels of d-Ng on the SHBG concentrations in the plasma. These findings support the concept that the clinically and biochemically observed anti-oestrogenic/androgenic effects observed in women on d-Ng containing medication are due to a displacement of testosterone from SHBG by d-Ng.
为了研究性激素结合球蛋白(SHBG)水平变化对血浆中炔诺孕酮(d-Ng)水平的影响,我们对6名服用含炔诺孕酮和炔雌醇(EOE2)口服避孕药的女性以及3名使用含炔诺孕酮皮下硅橡胶棒且同时服用炔雌醇三周的女性,在一个治疗周期内研究了其血浆中SHBG和d-Ng的水平。在所研究的9名受试者中,有7名受试者的SHBG和d-Ng水平之间存在显著正相关。结果表明,d-Ng在体内与SHBG结合,SHBG影响d-Ng的代谢清除率,进而导致血浆中d-Ng水平依赖于血浆中SHBG的浓度。这些发现支持了这样一种观点,即在服用含d-Ng药物的女性中临床和生化观察到的抗雌激素/雄激素作用是由于d-Ng将睾酮从SHBG上置换下来所致。